IGF-BPs control the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently, there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP5 is a 28.6 kDa, cysteine-rich, secreted protein produced by vascular smooth muscle cells. It is the major IGF-binding protein present in bone tissue and helps potentiate the action of IGF-I on smooth muscle cells, fibroblasts, and osteoblasts. Data shows that IGFBP-5 acts as a growth inhibitor and pro-apoptotic agent in breast cancer cells. IGFBP-5-overexpressing mice show an increase in neonatal mortality, reduced female fertility, whole-body growth inhibition, and retarded muscle development. Recombinant Human IGF-BP5 is a 28.6 kDa protein consisting of 253 amino acid residues.
Source: E.coli
Synonyms: Insulin-like Growth Factor-Binding Protein 5, IBP-5
AA Sequence: MLGSFVHCEP CDEKALSMCP PSPLGCELVK EPGCGCCMTC ALAEGQSCGV YTERCAQGLR CLPRQDEEKP LHALLHGRGV CLNEKSYREQ VKIERDSREH EEPTTSEMAE ETYSPKIFRP KHTRISELKA EAVKKDRRKK LTQSKFVGGA ENTAHPRIIS APEMRQESEQ GPCRRHMEAS LQELKASPRM VPRAVYLPNC DRKGFYKRKQ CKPSRGRKRG ICWCVDKYGM KLPGMEYVDG DFQCHTFDSS NVS
Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.
Biological Activity: The ED50 was determined by its ability to inhibit IGF-II induced proliferation of MCF-7 is ≤ 0.3 μg/ml in the presence of 15 ng/ml of human IGF-II.
Calculated Molecular Weight: 28.6 kDa
Accession Number: P24593
Gene ID: 3488
Endotoxin: Endotoxin level is < 0.1 ng/ug of protein (< 1 EU/ug)
crossreactivity:
Human
企业名称
上海远慕生物科技有限公司
企业信息已认证
企业类型
有限责任公司(自然人独资)
信用代码
91310120071207690P
成立日期
2013-06-19
注册资本
人民币300.0000万元整
经营范围
从事生物科技领域内的技术开发、技术咨询、技术服务、技术转让,实验室设备、化工原料及产品(除危险化学品、监控化学品、烟花爆竹、民用爆炸物品、易制毒化学品)、仪器仪表、五金交电、电子产品、机械设备、计算机、软件及辅助设备(除计算机信息系统安全专用产品)、电动自行车的批发、零售.(依法须经批准的项目,经相关部门批准后方可开展经营活动)
上海远慕生物科技有限公司
公司地址
上海浦东新区
客服电话